Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Secondary Benefits GLP-1 drugs also appear to have some extra benefits
M.QiaoF.et al (2019)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
EFRUXIFERMIN Efruxifermin is a bivalent FGF21 analog with direct antifibrotic actions and indirect effects on glucose and lipid metabolism, administered subcutaneously weekly
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
